Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et al.

Authors	M Ikeda, S Shimizu, T Sato, M Morimoto, Y Kojima, Y Inaba, A Hagihara, M Kudo, S Nakamori, S Kaneko, R Sugimoto, T Tahara, T Ohmura, K Yasui, K Sato, H Ishii, J Furuse, T Okusaka
Journal	Annals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 28 Issue 4 Pg. 903-904 (04 01 2017) ISSN: 1569-8041 [Electronic] England
PMID	28137738 (Publication Type: Letter, Research Support, Non-U.S. Gov't, Comment)
Chemical References	Phenylurea Compounds Niacinamide Sorafenib Cisplatin
Topics	Antineoplastic Combined Chemotherapy Protocols Carcinoma, Hepatocellular Cisplatin Humans Infusions, Intra-Arterial Liver Neoplasms Niacinamide (analogs & derivatives) Phenylurea Compounds Sorafenib

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!